Virtu KCG Holdings’s Medicines Co MDCO Stock Holding History

Virtu KCG Holdings’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$347K	Sell	9,126 -21,428	-70%	-$954K	0.01%	1505
2017 Q1	$1.49M	Sell	30,554 -11,197	-27%	-$511K	0.04%	423
2016 Q4	$1.42M	Buy	41,751 +23,110	+124%	+$820K	0.03%	506
2016 Q3	$704K	Buy	18,641 +9,848	+112%	+$371K	0.02%	1034
2016 Q2	$296K	Sell	8,793 -1,710	-16%	-$60.3K	0.01%	1892
2016 Q1	$334K	Buy	+10,503	New	+$343K	0.01%	1597
2015 Q4	–	Sell	-6,792	Closed	-$258K	–	4124
2015 Q3	$258K	Sell	6,792 -16,056	-70%	-$564K	﹤0.01%	2274
2015 Q2	$654K	Buy	+22,848	New	+$636K	0.01%	1252
2014 Q2	–	Sell	-9,024	Closed	-$256K	–	4207
2014 Q1	$256K	Buy	+9,024	New	+$299K	﹤0.01%	2698
2013 Q4	–	Sell	-8,062	Closed	-$270K	–	4409
2013 Q3	$270K	Buy	+8,062	New	+$257K	﹤0.01%	2745

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtu KCG Holdings's MDCO Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Medicines Co (MDCO) stake by 70% in Q2 2017, selling an estimated $954K and leaving 9,126 shares worth $347K. The position accounts for 0.01% of the portfolio, ranked #1505.

Virtu KCG Holdings first reported a position in MDCO in Q3 2013 and has held it in 10 quarters since. The position peaked at $1.49M in Q1 2017. 202 funds tracked by Wall St. Rank hold MDCO as of Q2 2017.

Virtu KCG Holdings held 9,126 shares of Medicines Co worth $347K as of Q2 2017.
Virtu KCG Holdings sold 21,428 Medicines Co shares in Q2 2017, an estimated $954K.
Medicines Co made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1505 holding.
Virtu KCG Holdings first reported a position in Medicines Co in Q3 2013 and has held it in 10 quarters since.
Virtu KCG Holdings's Medicines Co position peaked at $1.49M in Q1 2017.
202 funds tracked by Wall St. Rank held Medicines Co as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.